|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||1.65 / 6.49|
-- IGNITE study showed Contrave combined with a commercially-available weight loss program yielded nearly 10 percent body weight loss that persisted for 78 weeks --
Campaign Aims to Showcase Attributes and Benefits of FDA-approved CONTRAVE®
Here's a technical look at how to trade several under-$10 stocks that are poised for breakouts.
These under -$10 stocks are poised to breakout and trade higher from current levels.
Orexigen has shipped the first order of Contrave tablets to partner Kwang Dong in anticipation of a commercial launch later this quarter